Canada markets open in 5 hours 20 minutes

Ultimovacs ASA (ULTI.OL)

Oslo - Oslo Delayed Price. Currency in NOK
Add to watchlist
7.10+0.17 (+2.45%)
As of 09:53AM CEST. Market open.
Currency in NOK

Valuation Measures4

Market Cap (intraday) 238.43M
Enterprise Value -24.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.85
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.01
52-Week Change 3-94.54%
S&P500 52-Week Change 321.08%
52 Week High 3178.60
52 Week Low 36.07
50-Day Moving Average 347.08
200-Day Moving Average 390.02

Share Statistics

Avg Vol (3 month) 31.53M
Avg Vol (10 day) 3870.08k
Shares Outstanding 534.41M
Implied Shares Outstanding 634.41M
Float 824.19M
% Held by Insiders 131.03%
% Held by Institutions 121.13%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.40%
Return on Equity (ttm)-51.94%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -214.85M
Net Income Avi to Common (ttm)-189.24M
Diluted EPS (ttm)-5.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)266.56M
Total Cash Per Share (mrq)7.75
Total Debt (mrq)3.71M
Total Debt/Equity (mrq)1.33%
Current Ratio (mrq)4.85
Book Value Per Share (mrq)8.12

Cash Flow Statement

Operating Cash Flow (ttm)-189.83M
Levered Free Cash Flow (ttm)-103.22M